FDA Inspection 1303460 — Jonathan D. Harper, MD

Jonathan D. Harper, MD — FEI 3041669486

The FDA completed an inspection of Jonathan D. Harper, MD on February 12, 2026 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 12, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Seattle, WA (United States)

Additional Details

Clinical Investigator (CI)